{
    "root": "d2d71458-ab2e-4d49-b988-481f0764f9df",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Methylphenidate Hydrochloride",
    "value": "20240403",
    "ingredients": [
        {
            "name": "METHYLPHENIDATE HYDROCHLORIDE",
            "code": "4B3SC438HI",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31836"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "POLYETHYLENE GLYCOL 1450",
            "code": "OJ4Z5Z32L4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "GRAPE",
            "code": "6X543N684K",
            "drugbank_id": "https://go.drugbank.com/drugs/DB10533"
        }
    ],
    "indications": {
        "text": "methylphenidate hydrochloride oral solution indicated treatment : \u2022 attention deficit hyperactivity disorder ( adhd ) adults pediatric patients 6 years age older \u2022 narcolepsy",
        "doid_entities": [
            {
                "text": "attention deficit hyperactivity disorder (DOID:1094)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1094"
            },
            {
                "text": "narcolepsy (DOID:8986)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8986"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "pediatric patients 6 years older : starting dose 5 mg twice daily ( breakfast lunch ) ; increase dose 5 mg 10 mg weekly ; daily 60 mg recommended . ( 2.2 ) adults : administer divided doses 2 3 times daily , preferably 30 45 minutes meals . average 20 30 mg daily . maximum recommended daily 60 mg. ( 2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "supplied methylphenidate hydrochloride oral solution 5 mg per 5 ml colorless , grape flavored liquid . supplied bottles 500 ml , ndc 72162-2040-5. storage handling store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight container child-resistant closure . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "methylphenidate hydrochloride oral solution contraindicated patients : known hypersensitivity methylphenidate components methylphenidate hydrochloride oral solution . hypersensitivity angioedema anaphylactic reported patients treated methylphenidate [ ( 6 ) ] . receiving concomitant treatment monoamine oxidase inhibitors ( maois ) , within 14 days following discontinuation treatment maoi , risk hypertensive crises [ ( 7 ) ] .",
    "indications_original": "Methylphenidate hydrochloride oral solution is indicated for the treatment of:\n                  \u2022 Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years of age and older\n                  \u2022 Narcolepsy",
    "contraindications_original": "Pediatric patients 6 years and older: Starting dose is 5 mg twice daily (before breakfast and lunch); increase the dose 5 mg to 10 mg weekly; daily dosage above 60 mg is not recommended. ( 2.2 ) Adults: Administer in divided doses 2 or 3 times daily, preferably 30 to 45 minutes before meals. Average dosage is 20 to 30 mg daily. Maximum recommended daily dosage is 60 mg. ( 2 )",
    "warningsAndPrecautions_original": "How Supplied\n                  \n                  Methylphenidate hydrochloride oral solution 5 mg per 5 mL is a colorless, grape flavored liquid. It is supplied in bottles of 500 mL, NDC 72162-2040-5.\n                  \n                     Storage and Handling\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].\n                  Dispense in tight container with child-resistant closure.\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Methylphenidate hydrochloride oral solution is contraindicated in patients:\n                  \n                     with known hypersensitivity to methylphenidate or other components of methylphenidate hydrochloride oral solution. Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with methylphenidate [see Adverse Reactions (\n                        \n                           6\n                        \n                        )].\n                     receiving concomitant treatment with monoamine oxidase inhibitors (MAOIs), or within 14 days following discontinuation of treatment with an MAOI, because of the risk of hypertensive crises [see Drug Interactions (\n                        \n                           7\n                        \n                        )].",
    "drug": [
        {
            "name": "Methylphenidate Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31836"
        }
    ]
}